Compare UGI & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UGI | BRKR |
|---|---|---|
| Founded | 1940 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Laboratory Analytical Instruments |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 7.3B |
| IPO Year | N/A | 2000 |
| Metric | UGI | BRKR |
|---|---|---|
| Price | $38.26 | $37.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 13 |
| Target Price | $44.00 | ★ $52.08 |
| AVG Volume (30 Days) | ★ 2.7M | 2.4M |
| Earning Date | 02-04-2026 | 02-12-2026 |
| Dividend Yield | ★ 3.94% | 0.47% |
| EPS Growth | ★ 6.31 | N/A |
| EPS | ★ 2.71 | N/A |
| Revenue | ★ $7,340,000,000.00 | $3,438,900,000.00 |
| Revenue This Year | $8.88 | $3.64 |
| Revenue Next Year | $2.27 | $1.52 |
| P/E Ratio | $14.05 | ★ N/A |
| Revenue Growth | 3.10 | ★ 6.10 |
| 52 Week Low | $29.03 | $28.53 |
| 52 Week High | $41.34 | $56.22 |
| Indicator | UGI | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 49.87 | 25.29 |
| Support Level | $36.93 | $40.85 |
| Resistance Level | $40.98 | $42.58 |
| Average True Range (ATR) | 1.05 | 1.97 |
| MACD | -0.23 | -0.79 |
| Stochastic Oscillator | 33.56 | 5.72 |
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.